These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23804426)

  • 21. Graphene oxide polarizes iNKT cells for production of TGFβ and attenuates inflammation in an iNKT cell-mediated sepsis model.
    Lee SW; Park HJ; Van Kaer L; Hong S; Hong S
    Sci Rep; 2018 Jul; 8(1):10081. PubMed ID: 29973666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α-galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice.
    Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
    J Cell Mol Med; 2019 Feb; 23(2):1072-1085. PubMed ID: 30421497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials.
    Zhang Y; Springfield R; Chen S; Li X; Feng X; Moshirian R; Yang R; Yuan W
    Front Immunol; 2019; 10():1126. PubMed ID: 31244823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells.
    Melo AM; Zhang L; Dockry ÉF; Petrasca A; Ghnewa YG; Breen EP; Morrissey ME; O'Reilly C; Bruen R; O'Meara A; Lysaght J; Zhu X; Doherty DG
    Glycobiology; 2018 Jul; 28(7):512-521. PubMed ID: 29688330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza.
    Barthelemy A; Ivanov S; Hassane M; Fontaine J; Heurtault B; Frisch B; Faveeuw C; Paget C; Trottein F
    mBio; 2016 Nov; 7(6):. PubMed ID: 27803187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity.
    Chennamadhavuni D; Saavedra-Avila NA; Carreño LJ; Guberman-Pfeffer MJ; Arora P; Yongqing T; Pryce R; Koay HF; Godfrey DI; Keshipeddy S; Richardson SK; Sundararaj S; Lo JH; Wen X; Gascón JA; Yuan W; Rossjohn J; Le Nours J; Porcelli SA; Howell AR
    Cell Chem Biol; 2018 May; 25(5):571-584.e8. PubMed ID: 29576533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
    Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
    Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Invariant Natural Killer T Cell Subsets in C57BL/6J Mice by Different Injection Modes of α-galactosylceramide.
    Meng M; Chen S; Gao X; Liu H; Zhao H; Zhang J; Zhang J; Chen D
    Iran J Allergy Asthma Immunol; 2020 Feb; 19(1):35-44. PubMed ID: 32245319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.
    Saubermann LJ; Beck P; De Jong YP; Pitman RS; Ryan MS; Kim HS; Exley M; Snapper S; Balk SP; Hagen SJ; Kanauchi O; Motoki K; Sakai T; Terhorst C; Koezuka Y; Podolsky DK; Blumberg RS
    Gastroenterology; 2000 Jul; 119(1):119-28. PubMed ID: 10889161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.
    Gately CM; Podbielska M; Counihan T; Hennessy M; Leahy T; Moran AP; Hogan EL; O'Keeffe J
    J Neuroimmunol; 2013 Jun; 259(1-2):1-7. PubMed ID: 23537888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal mucus-derived nanoparticle-mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice.
    Deng ZB; Zhuang X; Ju S; Xiang X; Mu J; Wang Q; Jiang H; Zhang L; Kronenberg M; Yan J; Miller D; Zhang HG
    Hepatology; 2013 Mar; 57(3):1250-61. PubMed ID: 22991247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
    Wang Y; Sedimbi SK; Löfbom L; Besra GS; Porcelli SA; Cardell SL
    Front Immunol; 2019; 10():352. PubMed ID: 30881361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.
    Chang WS; Kim JY; Kim YJ; Kim YS; Lee JM; Azuma M; Yagita H; Kang CY
    J Immunol; 2008 Nov; 181(10):6707-10. PubMed ID: 18981087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
    Parekh VV; Wu L; Olivares-Villagómez D; Wilson KT; Van Kaer L
    J Immunol; 2013 Mar; 190(5):1948-60. PubMed ID: 23345328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
    Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
    J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.
    Kerzerho J; Yu ED; Barra CM; Alari-Pahissa E; Girardi E; Harrak Y; Lauzurica P; Llebaria A; Zajonc DM; Akbari O; Castaño AR
    J Immunol; 2012 Mar; 188(5):2254-65. PubMed ID: 22301545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infiltration of invariant natural killer T cells occur and accelerate brain infarction in permanent ischemic stroke in mice.
    Wang ZK; Xue L; Wang T; Wang XJ; Su ZQ
    Neurosci Lett; 2016 Oct; 633():62-68. PubMed ID: 27637387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors.
    Li YR; Zhou Y; Wilson M; Kramer A; Hon R; Zhu Y; Fang Y; Yang L
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.